We're getting a head start on the new year with the publication of 2015 Oncology Nursing Drug Handbook by Gail M. Wilkes and Margaret Barton-Burke.
Written especially for nurses caring for patients with cancer, it uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.
Completely revised and updated, the 2015 Oncology Nursing Drug Handbook includes a simplified chapter on molecular and biological targeted therapy that incorporates new information about immunotherapy, new indications, and the most important and common side effects.
New drug entries include: afatinib, belinostat, ceritinib, ibrutinib, idelalisib, obinutuzumab, pembrolizumab, ramucirumab, siltuximab, and mercaptopurine oral suspension.
Interested in learning more? Visit our website.